Extending Outcomes for Pancreas Cancer Patients With Nominal Oligometastatic Disease (EXPAND): A Randomized Phase III Trial
Clinical trial NCT06593431 · RECRUITING
Trial details
- NCT number
- NCT06593431
- Sponsor
- M.D. Anderson Cancer Center
- Status
- RECRUITING
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2024-10-23
- Primary completion
- 2029-06-29
- Enrollment
- 80
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.